Model:7501314706228
Current Reviews:0
Price:$24.00
Viternum Appetite Stimulant Syrup, Dihexazina
Appetite Stimulant
(Dihexazina)
Dosage form:
Of mixing 100 ml of syrup contains:
Dihexazina 60 mg
Vehicle c.b.p. 100 ml.
INDICATIONS: Stimulates the appetite, aid in the treatment of anorexia, malnutrition states, thinning and convalescence.
Pharmacokinetics VITERNUM is dihexazina lowering drug activity satiety center of the hypothalamus by stimulating the lateral center and, therefore, stimulating the appetite.
VITERNUM stimulates the longitudinal growth of children and weight gain.
VITERNUM is well tolerated orally, with peak concentration of 2.5 ng / ml for about 4 to 5 hours.
Although plasma levels obtained are low, are sufficient and remain the right time to exert its pharmacological effect. Its elimination half-life is 15 hours.
Hypersensitivity to the components of the formula, children under 2 years, pregnancy and lactation, narrow angle glaucoma, prostatic hypertrophy, stenosing peptic ulcer and gallbladder obstruction.
PRECAUTIONS: In children younger than 2 years has not been established dosage schedule. It is not recommended to exceed the suggested dosage. Should not be used continuously for periods over 12 weeks.
RESTRICTIONS OF USE DURING PREGNANCY AND BREAST-FEEDING: Do not use during pregnancy, lactation or in children under 2 years.
ADVERSE REACTIONS: Occasionally sedation can occur and are usually transient sleepiness in some patients may cause headache, dry mouth, nausea, vomiting, palpitations, and blurred vision without having to discontinue treatment.
DRUG INTERACTIONS: VITERNUM may potentiate the effects of other histamine antagonists should not be used concomitantly with protease inhibitors used for the treatment of AIDS, serotonin reuptake inhibitors used as antidepressants or alcohol.
CHANGES IN RESULTS OF LABORATORY TESTS: So far unknown.
PRECAUTIONS IN RELATION TO EFFECTS Carcinogenesis, Mutagenesis, Impairment of Fertility: In studies has not been demonstrated in terms of carcinogenicity, mutagenicity, teratogenicity or fertility.
DOSAGE AND ADMINISTRATION: Oral.
Children 2-4 years: 5 ml.
Children 4-10 years: 10 ml.
Older children and adults: 15 ml.
Always before each meal, 3 times daily.
MANIFESTATIONS AND MANAGEMENT OF OVERDOSE OR ACCIDENTAL INGESTION: So far at recommended doses no information of deliberate or accidental overdose, however, if this were to happen should be symptomatic drugs and supportive measures (gastric lavage and activated charcoal ).
PRESENTATION:
Bottle with 140 ml of sweetening syrup flavored strawberry and a vial containing 84 mg of active ingredient dihexazina, which must be mixed before use.
Once prepared syrup, 10 ml containing 6 mg of dihexazina.
RECOMMENDED STORAGE: Store at room temperature to no more than 30 ° C temperature. Of mixing the product is stored for 30 days at room temperature.
LEGENDS OF PROTECTION
Exclusively for medical literature. Keep out of reach of children. Its sale requires a prescription.
SENOSIAIN LABORATORIES, SA de CV
- Drug Name: viternum
- Comparative Brand: Viternum
- Active ingredient: dihexazina
- Presentation: Tablets
- Concentration: 140 ml
- Response time: No
- Laboratory senoseain
- Box of 1 bottle of syrup
- Manufactured in: Mexico
